“…Some authors said that these current neonatal scales present major limitations (García‐Fernández et al., ; Kottner et al., ). Neonatal scales include: the Neonatal Skin Condition Scale (Lund & Osborne, ), which is not specific for PU risk assessment and its study validation did not assess the PU, rather only skin condition and the prevalence of skin infection; the Seton scale (Vance, Demel, Kirksey, Moynihan, & Hollis, ), which remains under preparation and cannot be used because it is not fully designed and validated; the Neonatal/Infant Braden Q scale (Ashworth & Briggs, ), which is currently under validation (de Lima, de Brito, Souza, Salome, & Ferreira, ), a free adaptation of the Braden Q scale with the addition of the subscale “General Physical Condition” from the Neonatal Skin Risk Assessment Scale (NSRAS); the Glamorgan scale (Willock, Baharestani, & Anthony, ), designed for children from birth to 14 years old, evaluated in a retrospective study with inappropriate inter‐rater reliability measures, only provide information about the degree and direction of association; and the NSRAS (Huffines & Logsdon, ), based on the adult Braden scale, with a convenience sampling, small sample size and the missing replications. None of the described scales has been validated properly.…”